Resveratrol and prednisolone loaded into human serum albumin nanoparticles for the alleviation of rheumatoid arthritis symptoms: an in vitro and in vivo study
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Fig. 1.
SEM images of (A) RESALNPs, (B) PREALNPs, and (C) drug-free ALNPs. Right panel shows the size distribution of each nanocarrier
Fig. 2.
MTT assay with MG-63 cells cultured with RESALNPs, PREALNPs, and ALNPs during 7-day culture. * shows p-value < 0.05
Fig. 3.
Anti-inflammatory assay results with RESAL-NPs and PREALNPs compared with ALNPs and cells cultured with the normal media as the control group, * shows p-value < 0.05
Fig. 4.
Release of resveratrol and prednisolone from ALNPs during the course of 14 days in PBS
Fig. 5.
Hematoxylin and Eosin (H&E) and Masson’s trichrome staining images of cartilage tissue in different groups
Fig. 6.
Tissue concentrations of TNF-α, TGF-β, and IL-6 in cartilage tissue treated with different nanocarriers, * shows p-value < 0.05